Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas

Human and Experimental Toxicology

Volumn 25, Issue 9, 2006, Pages 515-522

  De Almeida Simão, Tatiana ^a   De Bonis Almeida Simões, Gabriela Loureiro ^a   Ribeiro, Fabiana Siqueira ^a   De Paula Cidade, Daniela Anhel ^a   Andreollo, Nelson Adami ^b   Lopes, Luiz Roberto ^b   Brito Macedo, Jacyara Maria ^a   Acatauassu, Rodolfo ^c   Rossini Teixeira, Ana Maria ^a   Felzenszwalb, Israel ^a   Ribeiro Pinto, Luis Felipe ^a   Albano, Rodolpho Mattos ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Cancer; DNMT; Oesophagus; p14ARF; p16INK4a

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; PROTEIN P14ARF; PROTEIN P16INK4A; UVOMORULIN;

ADULT; AGED; AMPLICON; ARTICLE; BRAZIL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DATA ANALYSIS; ENZYME ACTIVITY; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE INACTIVATION; HUMAN; HUMAN TISSUE; MALE; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATCHED-PAIR ANALYSIS; METHYLATION; MIDDLE AGED; MUCOUS MEMBRANE; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 33748762201     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327106het649oa     Document Type: Article

References (35)

1. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M, Fukai Y, Sohda M, Kimura H, Faried A. Genetic alterations in esophageal cancer. Surgery Today 2005; 35: 7-18.
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-46.
3. Lam AKY. Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 2000; 33: 71-90.
4. Ribeiro-Pinto LF, Teixeira-Rossini AM, Albano RM, Felzenszwalb I, de Moura-Gallo CV, Nunes RA, Andreollo NA. Mechanisms of esophageal cancer development in Brazilians. Mutat Res 2003; 544, 365-73.
5. Yang CS. Research on esophageal cancer in China: a review. Cancer Res 1980; 40: 2633-44.
6. Joint Iran-International Agency for Research on Cancer Study Group. Esophageal cancer studies in the Caspian littoral of Iran: results of population studies - a prodrome. J Natl Cancer Inst 1977; 59: 1127-38.
7. Parkin M, Muir CS, Wheelan SL, Gao Y-T, Ferlay J, Powell J. Cancer incidence in five continents, Vol. VI (IARC Scientific Publication No. 120). International Agency for Research on Cancer, 1992.
8. Prolla JC, Dietz J, da Costa LA. Diferenças Geográficas na mortalidade por câncer de esôfago no Rio Grande do Sul. Rev Assoc Med Bras 1993; 39: 217-20.
9. Brazilian Health Ministry. Atlas de mortalidade por câncer, Instituto Nacional de Câncer (INCA). Retrieved August 2005, from http://www.inca.gov.br.
10. Allen JW, Richardson JD, Edwards MJ. Squamous cell carcinoma of the esophagus: a review and update. Surg Oncol 1997; 6: 193-200.
11. Nie Y, Liao J, Zhao X, Song Y, Yang G, Wang LD, Yang CS. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 2002; 23: 1713-30.
12. Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 2002; 12: 373-79.
13. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-91.
14. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-28.
15. Tokugawa T, Sugihara H, Tani T, Hattori T (2002) Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 2002; 62: 4938-44.
16. Smeds J, Berggren P, Ma X, Xu Z, Hemminki K, Kumar R. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16INK4a and p14ARF) and p53 genes are major targets for inactivation. Carcinogenesis 2002; 23: 645-55.
17. El-Osta A. DNMT cooperativity - the developing links between methylation, chromatin structure and cancer. Bioessays 2003; 25: 1071-84.
18. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6-21.
19. Corn PG, Heath EI, Heitmiller R, Fogt F, Forastiere AA, Herman JG, Wu TT. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma. Clin Cancer Res 2001; 7: 2765-69.
20. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-29.
21. Robottom-Ferreira AB, Ribeiro-Pinto LF, Albano, RM. An optimized reverse transcription-polymerase chain reaction procedure for the amplification of low-copy Cyp2a3 mRNA in rat esophagus. Anal Biochem 2003; 319: 323-26.
22. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27: 2291-98.
23. Park MJ, Shimizu K, Nakano T, Park YB, Kohno T, Tani M, Yokota J. Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma. Cancer Genet Cytogenet 2003; 141: 5-13.
24. Raff T, van der Giet M, Endemann D, Wiederholt T, Paul M. Design and testing of β-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 1997; 23: 456-60.
25. Girault I, Tozlu S, Lidereau R, Bieche I. Expression analysis of DNA methyltransferases 1, 3a and 3b in sporadic breast carcinomas. Clin Cancer Res 2003; 9: 4415-22.
26. Nagai M, Nakamura A, Makino R, Mitamura K. Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol Res 2003; 26: 186-91.
27. Kanal Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S. DNA methyltransferase expression and DNA methylation of CpG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 2001; 91: 205-12.
28. Bonfils C, Beaulieu N, Chan E, Cotton-Montpetit J, MacLeod R. Characterization of the human DNA methyltransferase splice variant dnmt1b. J Biol Chem 2000; 275: 10754-60.
29. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc Natl Acad Sci 2002; 99: 10060-65.
30. Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999; 5: 2704-13.
31. Guner D, Sturm I, Hemmati P, Hermann S, Hauptmann S, Wurm R, Budach V, Dorken B, Lorenz M, Daniel PT. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis. Int J Cancer 2003; 103: 445-54.
32. Taniere P, Martel-Planche G, Saurin JC, Lombard-Bohas C, Berger F, Scoazec JY, Hainaut P. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer 2001; 85: 721-26.
33. Mizuno SI, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H. Expression of DNA methyltransferases dnmt1, 3a and 3b in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001; 97: 1172-79.
34. Ahluwalia A, Hurteau JA, Bigsby RM, Nephew KP. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Gynecol Oncol 2001; 82: 299-304.
35. Kopelovich L, Crowell JA, Fay JR. The epigenome as a target for cancer chemoprevention. J Natl Cancer Inst 2003; 95: 1747-57.